EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark SynOx was filed as Word mark on 05/27/2021 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/01/2021.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 018480230 |
| Application date | May 27, 2021 |
| Publication date | June 25, 2021 |
| Entry date | October 1, 2021 |
| Expiration date | May 27, 2031 |
Trademark owner
7/8 Wilton Terrace
D02 KC57 Dublin 2
IE
D02 KC57 Dublin 2
IE
Trademark representatives
Velazquez 51 4º Derecha
28001 Madrid
ES
goods and services
5
Humanised antibody-based drugs for the treatment, diagnosis, detection and/or prevention of cancer and/or other diseases; humanised antibody emactuzumab targeting the CSF1R (colony stimulating factor 1 receptor) in cancer; inhibitors of CSF1R and macrophage function for the treatment of cancer and/or other diseases; inhibitors of protein arginine methyl-transferase (PRMT) for the treatment of TGCT (tenosynovial giant cell tumour) / PVNS (pigmented villonodular synovitis); compounds for the treatment, diagnosis, detection and/or prevention of cancer and/or other diseases; pharmaceutical products, preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer and/or other diseases; biological preparations and substances for the treatment, diagnosis, detection and/or prevention of cancer and/or other diseases
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 30, 2024 | RAW: Rights in rem - Creation of rights in rem, Published | ||
| August 18, 2021 | Change Representative, Registered | ||
| August 11, 2021 | Change Representative, Registered |
ID: 11018480230